» Articles » PMID: 38338328

Self-Assembled Molecular Complexes of 1,10-Phenanthroline and 2-Aminobenzimidazoles: Synthesis, Structure Investigations, and Cytotoxic Properties

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2024 Feb 10
PMID 38338328
Authors
Affiliations
Soon will be listed here.
Abstract

Three new molecular complexes (phen)(2-amino-Bz)(H)(BF)·3HO , (phen)(2-amino-5(6)-methyl-Bz)(H)(BF)·HO , and (phen)(1-methyl-2-amino-Bz)(H)(BF) , were prepared by self-assembly of 1,10-phenanthroline (phen) and various substituted 2-aminobenzimidazoles. Confirmation of their structures was established through spectroscopic methods and elemental analysis. The X-ray diffraction analysis revealed that the crystal structure of is stabilized by the formation of hydrogen bonds and short contacts. In addition, the molecular geometry and electron structure of molecules and were theoretically evaluated using density functional theory (DFT) methods. According to the DFT B3LYP/6-311+G* calculations, the protonated benzimidazole (Bz) units act as NH hydrogen bond donors, binding two phenanthrolines and a BF ion. Non-protonated Bz unit form hydrogen bonds with the N-atoms of a third molecule phen. The molecular assembly is held together by π-π stacking between benzimidazole and phenanthroline rings, allowing for N-atoms to associate with water molecules. The complexes were tested in vitro for their tumor cell growth inhibitory effects on prostate (PC3), breast (MDA-MB-231 and MCF-7), and cervical (HeLa) cancer cell lines using MTT-dye reduction assay. The in vitro cytotoxicity analysis and spectrophotometric investigation in the presence of ct-DNA, showed that self-assembled molecules - are promising DNA-binding anticancer agents warranting further in-depth exploration.

References
1.
Tahlan S, Kumar S, Kakkar S, Narasimhan B . Benzimidazole scaffolds as promising antiproliferative agents: a review. BMC Chem. 2019; 13(1):66. PMC: 6661752. DOI: 10.1186/s13065-019-0579-6. View

2.
Brana M, Cacho M, Gradillas A, de Pascual-Teresa B, Ramos A . Intercalators as anticancer drugs. Curr Pharm Des. 2001; 7(17):1745-80. DOI: 10.2174/1381612013397113. View

3.
Solomon V, Hu C, Lee H . Design and synthesis of anti-breast cancer agents from 4-piperazinylquinoline: a hybrid pharmacophore approach. Bioorg Med Chem. 2010; 18(4):1563-72. DOI: 10.1016/j.bmc.2010.01.001. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
Rajarajeswari C, Ganeshpandian M, Palaniandavar M, Riyasdeen A, Akbarsha M . Mixed ligand copper(II) complexes of 1,10-phenanthroline with tridentate phenolate/pyridyl/(benz)imidazolyl Schiff base ligands: covalent vs non-covalent DNA binding, DNA cleavage and cytotoxicity. J Inorg Biochem. 2014; 140:255-68. DOI: 10.1016/j.jinorgbio.2014.07.016. View